AKT1 and cancer: The DEGs were significantly enriched in the PI3K-Akt signaling pathway, ECM-receptor interaction, and the IL-17 signaling pathway (Figure 8C), all of which are known to be crucial for cell proliferation, survival, and inflammation in cancer.